MOESM2 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets

  • Chia Hung Chien (Contributor)
  • Jian-Ying Chuang (Contributor)
  • Shung-Tai Yang (Contributor)
  • Wen-Bin Yang (Contributor)
  • Pin Yuan Chen (Contributor)
  • Tsung-I Hsu (Contributor)
  • Chih Yuan Huang (Contributor)
  • Wei-Lun Lo (Contributor)
  • Ka-Yen Yang (Contributor)
  • Ming Sheng Liu (Contributor)
  • Jui Mei Chu (Contributor)
  • Pei Hsuan Chung (Contributor)
  • Jr Jiun Liu (Contributor)
  • Shao Wen Chou (Contributor)
  • Shang Hung Chen (Contributor)
  • Kwang Yu Chang (Contributor)

資料集

Description

Additional file 2: Figure S2. Kaplan-Meier curves of an array database from SurvExpress ( http://bioinformatica.mty.itesm.mx:8080/Biomatec/SurvivaX.jsp ) [18]. The original data included samples of (A) GBM from Joo KM, et al., 2013 ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42669 ), (B) low-grade glioma and GBM from Phillips HS, et al., 2006 ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE4271 ), and (C) low-grade glioma and GBM from TCGA. Each line refers to cases in which SOD2 gene expression was higher or lower than the median.
可用日期一月 1 2019
發行者Unknown Publisher

引用此